Ipsen Pays $1.3 Billion for Clementia

05.03.2019 - French drugmaker Ipsen has agreed to buy Canada’s Clementia Pharmaceuticals, boosting its rare disease portfolio. Ipsen will pay $1.04 billion for the clinical-stage biotechnology...